◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CVSG

CVS Group plc (CVSG) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-16

CVS Group plc (CVSG) operates in the Medical Care Facilities industry and is headquartered in Diss, United Kingdom with about 9,000 employees. Its market capitalization is roughly £891 million. In the fiscal year ended 2024-06-30, CVSG reported £639M in revenue and £6M in net income.

CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments.

Interactive charts & full statements →

CVSG Revenue & Earnings History — Annual Income Statement

Income statement2024-06-302023-06-302022-06-30
Total Revenue£639M£589M£554M
Gross Profit£269M£258M£239M
Operating Income (EBIT)£48M£68M£43M
Net Income£6M£42M£26M

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVSG Free Cash Flow History

Cash flow2025-06-302024-06-302023-06-302022-06-30
Dividends Paid(£5M)(£5M)(£5M)

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CVSG Balance Sheet History

Balance sheet2025-06-302024-06-302023-06-302022-06-30
Total Assets£690M£572M£518M
Total Liabilities£430M£315M£301M

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CVSG viewer.

Other Companies in Medical Care Facilities

← CVSAAll “C” companiesCVV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.